Definitive Contract 75N92021C00027
Award Date 9/30/21
Potential Completion Date 9/29/23
Potential Value $10M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Monmouth Junction, South Brunswick Township, NJ 08852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services, through its Office of the Assistant Secretary for Preparedness and Response, has awarded a $28,728,000.00 firm-fixed-price definitive contract to Princeton Biomeditech Corp (doing business as P B M) for the delivery of over-the-counter (OTC) COVID-19 tests. This contract, which has a completion date of March 19, 2025, does not utilize a set-aside designation. Princeton Biomeditech Corp is a manufacturer of rapid, point-of-care diagnostics,...
- This is a federal contract award from the Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) to Princeton Biomeditech Corp, doing business as P B M, for $9,885,816.00. The contract supports COVID-19 industrial base expansion efforts, including the development, production, and delivery of coronavirus diagnostics such as rapid, point-of-care tests, multiplex COVID-19 and influenza assays, and test readers. The contract is a definitive, firm-fixed-price contract with a completion...
- Princeton Biomeditech Corp, doing business as P B M, has been awarded a $1.46 million firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to provide flu testing support for coronavirus. The contract is for the delivery of coronavirus COVID-19 testing services and will be performed in Chamblee, Georgia over a six-month period concluding in September 2020. No subcontractors or set aside designations...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $19.3 million firm fixed price definitive contract to ANP Technologies Inc. to support the RADX TECH PROJECT #2620 for accelerated manufacturing scale-up of ANP Technologies' nano-intelligent detection system for COVID-19 antigen rapid testing. Performance will take place in Newark, Delaware over a two year period concluding in December 2022. No set aside designation or...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to Ascella Biosystems Inc., a for-profit manufacturer, on January 13, 2021. The $250,000.00 contract is for RADX-TECH - SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1 and is associated with the Coronavirus COVID-19 national interest action. The contract does not have a set-aside designation and is scheduled for completion on January...
- Minute Molecular Diagnostics, Inc. was awarded a definitive, firm fixed price contract valued at seventeen million, five hundred ninety thousand dollars by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for the RADX TECH PROJECT 2200 to develop a high-throughput, fast-turnaround, field-deployable COVID-19 molecular diagnostic system. Work will be performed in Evanston, Illinois with a period of performance...
- Flambeau Diagnostics LLC was awarded a definitive firm fixed-price contract valued at $22.57 million by the National Heart, Lung, and Blood Institute (NHLBI) on July 1, 2021, for the development of point-of-need, saliva-based COVID-19 testing platforms under the RADX Tech 2375 program. The contract was performed in Madison, Wisconsin, with an ultimate completion date of March 31, 2023. This award did not utilize a set-aside designation and represents a civilian agency procurement for critical...
- The U.S. National Institute of Biomedical Imaging and Bioengineering, part of the Department of Health and Human Services, awarded a $16,239,965.00 firm fixed price contract to Mologic Inc., a foreign-owned for-profit organization, for the Rapid Acceleration of Diagnostics (RADx) Program Tech Project #7697: SARS-CoV-2 Antigen Home Test. This contract, which does not have a set-aside designation, aims to deliver the testing products through January 2025 from Mologic's facility in Bedford, New...
- The National Institutes of Health awarded a $50.7 million firm fixed price modification to MicroGEM US Inc. under the RADX Tech Program. The modification extends an existing contract to maintain MicroGEM's production of 160,000 saliva-based, high-performing RT-PCR point-of-care cartridges and 1,000 portable devices per day for COVID-19 testing. The 25-minute tests and devices are non-invasive and portable. Funding comes from the Department of Health and Human Services National Institutes of...
- This definitive contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Biomedical Imaging and Bioengineering is valued at $1,462,373.11 to Ubiquitome Limited of New Zealand. Under the contract, Ubiquitome will support the RADX program's goal of accelerating diagnostic testing for SARS-CoV-2 by developing the Liberty16 mobile real-time PCR test to make accurate Covid-19 lab testing accessible to all Americans. The firm fixed price...